Poland· PL-100535535
Thiopental Inresa 0,5 g
A thiopental product containing thiopentalum natricum et natrii carbonas, registered in Poland by Delfarma Sp. z o.o.. The same ATC class is registered in 10 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Thiopental is registered in 10 of 19 countries.
Countries holding a registration under ATC N01AF03 (thiopental), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Thiopental · ATC N01AF03
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Thiopentalum natricum et natrii carbonas
- Manufacturer
- Delfarma Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- N01AF03
- ATC class
- Thiopental
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 4
- gtin05909991597801
- gtin05909991597788
- gtin05909991597795
- gtin05909991597818
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
56 interactions on record for thiopental.
Graded by severity as the source publishes them — 5 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Thiopental · interactions on record
56 records
- 5 severe
- 44 moderate
- 7 minor
Most severe, free to view
- WarfarinB01AA03severe
- EthanolB05XX04severe
- EthanolV03AB16severe
- EthanolV03AZ01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under N01AF03
Thiopental, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9e6283d7-d1da-45fa-9bb4-b5169756f5bc GET /v1/drugs/9e6283d7-d1da-45fa-9bb4-b5169756f5bc?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Proszek do sporządzania roztworu do wstrzykiwań",
"source": "urpl",
"strength": "500 mg",
"packaging": "05909991597788 ¦ Lz ¦ 166444\n1 fiol. 500 mg proszku\n05909991597795 ¦ Lz ¦ 166445\n10 fiol. 500 mg proszku\n05909991597801 ¦ Lz ¦ 166446\n25 fiol. 500 mg proszku\n05909991597818 ¦ Lz ¦ 166447\n50 fiol. 500 mg proszku",
"substance": "Thiopentalum natricum et natrii carbonas 500 mg",
"common_name": "Thiopentalum natricum et natrii carbonas",
"pl_product_id": "100535535",
"pozwolenie_nr": "122/26",
"auth_procedure": "IR",
"authorisation_validity": "2031-04-01"
}See everything about thiopental.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.